Clinical trials - Press Releases

Date	Title	Company
15-Mar-2023	Immutep announces initiation of phase II/III trial for eftilagimod alpha plus paclitaxel in metastatic breast cancer	Immutep
15-Mar-2023	Mural Health and ProofPilot Partner to Streamline Payments and Provide More Patient Choice	Discovery PR
13-Mar-2023	Greenphire Expands Agreement with Merck to Help Reduce Financial and Travel Barriers for Clinical Trial Participants Worldwide	Greenphire
13-Mar-2023	Calliditas Announces Primary Endpoint Successfully Met in Phase 3 NefIgArd Trial Evaluating Nefecon® in IgA Nephropathy	Calliditas
13-Mar-2023	New drug to lower brain pressure could treat blinding IIH headaches, trial finds	University of Birmingham
09-Mar-2023	Antev Receives US FDA Guidance on Teverelix® Phase 3 Trial Design for Treating Advanced Prostate Cancer Patients with Increased Cardiovascular Risk	Antev Ltd
08-Mar-2023	UK clinical trial for potential new endometriosis treatment, funded by Wellbeing of Women and the Scottish Government, offers hope to millions of women	Wellbeing of Women
07-Mar-2023	Dupixent® (dupilumab) application for treatment of chronic spontaneous urticaria (CSU) in adults and adolescents accepted for FDA review	Sanofi
07-Mar-2023	AB2 Bio Completes Enrolment in Pivotal Phase 3 Trial of Tadekinig alfa to Treat Primary Monogenic IL-18 Driven HLH	AB2 Bio
07-Mar-2023	Increasing female representation in science	Broughton Group
07-Mar-2023	Participants Dosed on Adessia® in Germany in a Phase 1 Trial, a First for an Adalimumab Biosimilar Candidate Developed in Africa	MiGenTra
07-Mar-2023	Cellbox Solutions Raises EUR 6.5 Million in Series A1 Financing Round	Cellbox Solutions
06-Mar-2023	GreenLight Clinical and Cure Therapeutics signs Letter of Intent exploring future business collaboration	GreenLight Clinical
02-Mar-2023	Completed XTEND-Kids Phase 3 study strengthens potential of ALTUVIIIO™ to redefine expectations for treatment of children <12 years of age with hemophilia A	Sanofi
02-Mar-2023	Positive Results from POLB 001 LPS Human Challenge Trial	Poolbeg Pharma
01-Mar-2023	Sequana Medical announces positive results from CHIHUAHUA, Phase 1 clinical trial of second-generation DSR product for congestive heart failure	Sequana Medical
28-Feb-2023	Greenphire's ConneX Global Travel Solution Expands In-Country Support, Resulting in Significant Growth as Clinical Trial Travel Returns Post-Pandemic	Greenphire
28-Feb-2023	mdgroup launches third fully compliant medical distribution centre in Europe	mdgroup
28-Feb-2023	HUTCHMED Completes Patient Enrollment of Phase II Registration Trial of Amdizalisib in Follicular Lymphoma in China	HUTCHMED
24-Feb-2023	Sangamo Therapeutics announces evidence of clinical benefit in phase 1/2 staar study in FABRY DISEASE	Sangamo Therapeutics